Arbuthnot Banking Group Future Growth
Future criteria checks 2/6
Arbuthnot Banking Group is forecast to grow earnings and revenue by 8.7% and 6.4% per annum respectively. EPS is expected to grow by 5.7% per annum. Return on equity is forecast to be 11.6% in 3 years.
Key information
8.7%
Earnings growth rate
5.7%
EPS growth rate
| Banks earnings growth | 0.4% |
| Revenue growth rate | 6.4% |
| Future return on equity | 11.6% |
| Analyst coverage | Low |
| Last updated | 02 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 212 | 37 | N/A | N/A | 1 |
| 12/31/2025 | 192 | 31 | N/A | N/A | 2 |
| 12/31/2024 | 181 | 28 | N/A | N/A | 2 |
| 6/30/2024 | 179 | 31 | -110 | -85 | N/A |
| 3/31/2024 | 179 | 33 | -83 | -67 | N/A |
| 12/31/2023 | 178 | 35 | -56 | -50 | N/A |
| 9/30/2023 | 166 | 35 | -66 | -42 | N/A |
| 6/30/2023 | 154 | 34 | -41 | -35 | N/A |
| 3/31/2023 | 142 | 25 | -95 | -88 | N/A |
| 12/31/2022 | 129 | 16 | -148 | -141 | N/A |
| 9/30/2022 | 117 | 11 | -182 | -200 | N/A |
| 6/30/2022 | 106 | 5 | -251 | -258 | N/A |
| 3/31/2022 | 97 | 6 | -258 | -259 | N/A |
| 12/31/2021 | 89 | 7 | -265 | -259 | N/A |
| 9/30/2021 | 83 | 5 | -179 | -167 | N/A |
| 6/30/2021 | 78 | 3 | -93 | -74 | N/A |
| 3/31/2021 | 74 | 1 | -45 | -32 | N/A |
| 12/31/2020 | 70 | -1 | 2 | 9 | N/A |
| 9/30/2020 | 71 | 1 | -200 | -192 | N/A |
| 6/30/2020 | 72 | 4 | -403 | -394 | N/A |
| 3/31/2020 | 72 | 5 | -398 | -389 | N/A |
| 12/31/2019 | 72 | 6 | -392 | -385 | N/A |
| 9/30/2019 | 70 | 7 | -272 | -266 | N/A |
| 6/30/2019 | 68 | 7 | -152 | -147 | N/A |
| 3/31/2019 | 67 | 6 | -165 | -160 | N/A |
| 12/31/2018 | 65 | 6 | -178 | -173 | N/A |
| 6/30/2018 | 61 | 1 | -173 | -176 | N/A |
| 3/31/2018 | 57 | 1 | N/A | -209 | N/A |
| 12/31/2017 | 54 | 2 | N/A | -241 | N/A |
| 9/30/2017 | 51 | 6 | N/A | -218 | N/A |
| 6/30/2017 | 47 | 5 | N/A | -195 | N/A |
| 3/31/2017 | 45 | -29 | N/A | 351 | N/A |
| 12/31/2016 | 43 | -62 | N/A | 897 | N/A |
| 9/30/2016 | 40 | -68 | N/A | N/A | N/A |
| 6/30/2016 | 38 | -74 | N/A | 737 | N/A |
| 3/31/2016 | 36 | -45 | N/A | 118 | N/A |
| 12/31/2015 | 33 | -16 | N/A | -501 | N/A |
| 6/30/2015 | 46 | -8 | N/A | -567 | N/A |
| 3/31/2015 | 63 | -3 | N/A | -483 | N/A |
| 12/31/2014 | 80 | 2 | N/A | -400 | N/A |
| 9/30/2014 | 105 | 10 | N/A | -255 | N/A |
| 6/30/2014 | 102 | 12 | N/A | -111 | N/A |
| 3/31/2014 | 95 | 10 | N/A | -104 | N/A |
| 12/31/2013 | 88 | 8 | N/A | -98 | N/A |
| 9/30/2013 | 78 | 4 | N/A | -74 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RX20's forecast earnings growth (8.7% per year) is above the savings rate (0.8%).
Earnings vs Market: RX20's earnings (8.7% per year) are forecast to grow slower than the German market (20% per year).
High Growth Earnings: RX20's earnings are forecast to grow, but not significantly.
Revenue vs Market: RX20's revenue (6.4% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: RX20's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RX20's Return on Equity is forecast to be low in 3 years time (11.6%).